Study on the Effectiveness of Kala Basti and Karpasasthyadi Pinda Swedana with Nagar Churna in the Management of Rheumatoid Arthritis (Aamvata)

A Clinical Study to Evaluate the Efficacy of Kala Basti Along with Karpasasthyadi Pinda Swedan Followed by Nagar Churna in the Management of Aamvata (W.S.R. to Rheumatoid Arthritis) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088364

Enrollment

Registered

2025-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either sex aged 18 to 60 years Willing and able to participate in the study Diagnosed Amavata patients as per Ayurveda and 1987 ACR criteria for RA Chronicity less than 5 years Post chikungunya RA cases included if meeting diagnostic criteria

Exclusion criteria

Exclusion criteria: Patients with severe systemic diseases like cardiac disorders or cancer Patients below 18 years or above 60 years Pregnant or lactating women Chronicity more than 5 years Patients with gouty arthritis or osteoarthritis

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Kala Basti along with Karpasasthyadi Pinda Sweda followed by Nagar Churna on subjective and objective parameters of AmavataTimepoint: 30 Days	—

Secondary

Measure	Time frame
The secondary outcome includes observing any other effects of the drug & procedure, such as changes in inflammation, patient satisfaction, reduction in the need for conventional medications, & overall quality of life improvementsTimepoint: 16 days	—

Countries

India

Contacts

Public ContactDr Gyan Prakash Sharma

Post Graduate Institute of Ayurved

atreyagyan@gmail.com9829798701

Outcome results